ArticleClinical science (London, England : 1979)2025
Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.
Chloe Sligar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.